Dendreon is a biotechnology company focused on the discovery, development and commercialization of therapeutics for cancer treatment. PROVENGE® (sipuleucel-T) is Co.'s commercialized product, and is an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic, metastatic, castrate-resistant (hormone-refractory) prostate cancer. Co. owns worldwide rights for PROVENGE. Other product candidates under development include investigational cellular immunotherapies for the treatment of patients with bladder, breast, ovarian and other solid tumors; renal cell carcinoma; and colorectal and other cancers.

DNDN — Key Stats (updated 15 hours, 33 minutes ago)

Company Name:  Dendreon Corp Website:  www.dendreon.com Sector:  Biotechnology Number of ETFs Holding DNDN:  29 Total Market Value Held by ETFs:  $37,632,485 Total Market Capitalization:  $623,000,000 % of Market Cap. Held by ETFs:  6.04%

ETFs Holding DNDN

ETF   DNDN Weight   DNDN Amount   XBI   1.39%   $12,304,102           IWM   0.04%   $8,768,503           IBB   0.18%   $5,724,381           IWO   0.09%   $4,183,826           VBK   0.06%   $1,790,486           VB   0.03%   $1,613,028           BBH   0.31%   $1,041,019           VXF   0.02%   $465,605           VHT   0.03%   $442,888           EMV   0.79%   $210,517          List of all 29 ETFs holding DNDN »

DNDN — News

Featured Slideshows

10 ETFs With Stocks That Insiders Are Buying 25 Dividend Giants Widely Held By ETFs 25 S.A.F.E. Dividend Stocks Increasing Payments For Decades Broker Darlings: Top 15 Analyst Picks of the Dow Top 25 Broker Analyst Picks of the S&P 500 Forgotten S&P 500 Giants: Analysts' Current Least Favorites 25 Top Ranked Socially Responsible Dividend Stocks The Top 10 DividendRank'ed Stocks The DividendRank Top 25 The Top 10 DividendRank'ed DJIA Components The Top 10 DividendRank'ed Dow Transports Components The Top 10 DividendRank'ed Dow Utilities Components The Top 10 DividendRank'ed Nasdaq 100 Components 10 Stocks Going Ex-Dividend 10 Oversold Dividend Stocks 10 Stocks Where Yields Got More Juicy 10 Dividend Bargains You Can Buy Cheaper Than Insiders Did Top Ranked Dividend Stocks With Insider Buying 10 Energy Stocks You Can Buy Cheaper Than Insiders Did 10 Metals Stocks You Can Buy Cheaper Than Insiders Did 10 Oversold Metals Stocks 10 Must-Know High-Yield REITs 10 Top DividendRank'ed Financials 10 Top DividendRank'ed Metals Stocks 10 Oversold Energy Stocks 10 Top DividendRank'ed Energy Stocks 10 Top DividendRank'ed Utility Stocks 10 Stocks Crossing Below Book Value 10 Stocks Crossing Above Their 200 Day Moving Average 10 Stocks Crossing Below Their 200 Day Moving Average 10 ETFs Crossing Above Their 200 DMA The 10 Biggest ETFs The 10 Best ETF Performers The 10 Worst ETF Performers 10 ETFs With Notable Inflows 10 ETFs With Notable Outflows The Top 10 DividendRank'ed Canadian Stocks The DividendRank Canada Top 25 10 Canadian Stocks Going Ex-Dividend 10 Oversold Canadian Stocks 10 Canadian Stocks Where Yields Got More Juicy 10 Must-Know High-Yield Canadian Real Estate Stocks 10 Top DividendRank'ed Canadian Financials 10 Must-Know High-Yield Canadian Energy Stocks 10 Canadian Stocks Crossing Below Book Value 10 Canadian Stocks Crossing Above Their 200 Day Moving Avg 10 Canadian Stocks Crossing Below Their 200 Day Moving Avg

Advertising Opportunities on ETF Channel